Drug trial aims to tame tough thyroid tumors before surgeons operate
NCT ID NCT04321954
Summary
This study is testing if taking the drug lenvatinib before surgery can help control advanced thyroid cancer that has grown into nearby structures. The goal is to shrink the tumors, making them easier and safer to remove completely. About 30 adults with this specific type of invasive thyroid cancer will participate to see if this approach improves surgical outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.